Low-molecular-weight heparin-conjugated liposomes with improved stability and hemocompatibility

被引:3
|
作者
Köse, GT [1 ]
Arica, MY [1 ]
Hasirci, V [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey
关键词
conjugation; hemocompatibility; liposome stability; low molecular weight heparin; multilamellar liposome;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multilamellar vesicles (MLV) containing phosphatidyl choline (PC), cholestrol (CHOL), and stearylamine (SA) in the molar ratio of 7:2:0.2 were prepared by the thin film hydration method. Low-molecular-weight heparin (LMWH, MW: 3000) was conjugated with the MLV using carbodiimide (EDC), Infrared, Raman, and nuclear magnetic resonance spectra and DSC of each sample (MLV, LMWH, and MLV-LMWH) were obtained, enabling the authors to determine the chemical changes that occurred in the MLV structure at the end of the conjugation step. In addition, the changes in the chemical structures of the conjugated samples were revealed by the use of elemental analysis. Particle size analysis was used to determine the difference between the sizes of MLV and MLV-LMWH. In order to study the effect of LMWH on the behavior of MLV-LMWH in blood, osmotic fragility (in saline and plasma), hemolytic activity, and plasma recalcification time tests were carried out. These tests showed that it was possible to construct liposomes that would not induce reactions in the blood and would have potentially longer half-lives in the circulation.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 50 条
  • [31] DELAYED CUTANEOUS REACTION TO UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN AND DANAPAROID
    SIVAKUMARAN, M
    GHOSH, K
    MUNKS, R
    GELSTHORPE, K
    TAN, L
    WOOD, JK
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 893 - 894
  • [32] NO TRANSPLACENTAL PASSAGE OF STANDARD HEPARIN OR AN ENZYMATICALLY DEPOLYMERIZED LOW-MOLECULAR-WEIGHT HEPARIN
    MATZSCH, T
    BERGQVIST, D
    BERGQVIST, A
    HODSON, S
    DAWES, J
    HEDNER, U
    OSTERGAARD, P
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (02) : 273 - 278
  • [33] Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin
    Stief, Thomas W.
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (08) : 633 - 637
  • [34] TREATMENT OF VENOUS THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARIN AND FLUINDIONE
    FIESSINGER, JN
    PAUL, JF
    ALHENCGELAS, M
    VEYSSIER, C
    MARTIN, JB
    AIACH, M
    PRESSE MEDICALE, 1992, 21 (02): : 65 - 68
  • [35] The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects - Low-molecular-weight heparin versus unfractionated heparin
    Hull, RD
    Pineo, GF
    Raskob, GE
    HAEMOSTASIS, 1998, 28 : 8 - 16
  • [36] Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin
    Spinler, SA
    Wittkowsky, AK
    Nutescu, EA
    Smythe, MA
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1275 - 1285
  • [37] Low-molecular-weight heparin in women with repeated implantation failure
    Lodigiani, Corrado
    Di Micco, Pierpaolo
    Ferrazzi, Paola
    Libre, Luca
    Arfuso, Veronica
    Polatti, Franco
    Benigna, Michela
    Rossini, Roberta
    Morenghi, Emanuela
    Rota, Lidia
    Brenner, Benjamin
    Setti, Paolo Emanuele Levi
    WOMENS HEALTH, 2011, 7 (04) : 425 - 431
  • [38] Low-molecular-weight heparin-induced skin necrosis
    Füreder, W
    Kyrle, PA
    Gisslinger, H
    Lechner, K
    ANNALS OF HEMATOLOGY, 1998, 77 (03) : 127 - 130
  • [39] Update on the clinical use of the low-molecular-weight heparin, parnaparin
    Camporese, Giuseppe
    Bernardi, Enrico
    Noventa, Franco
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 819 - 831
  • [40] Treatment of submasive pulmonary embolism with low-molecular-weight heparin
    Bosch, MM
    MEDICINA CLINICA, 2000, 115 (09): : 343 - 346